- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Cardiology
The Endocrinology Network® Cardiology clinical resource center is a hub of news related to cardiovascular health that is relevant to clinicians interested in endocrinology. A leading cause of death among diabetics and a threat for many with other endocrine diseases, this page will host relevant content about cardiology and cardiovascular disease including guideline updates, new studies and breakthroughs, and clinical perspective for practicing clinicians.
Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease
April 14, 2021
A trial led by clinicians from Northwestern Medicine suggests the presence of ischemic leg symptoms could serve as a useful indicator for patients to help determine whether they will see a meaningful benefit from their walking program.
Case Report: Shortness of Breath and Worsening Leg Edema
April 12, 2021
Our latest case report from Dr. Brady Pregerson features a man in his 40s presenting with shortness of breath and worsening leg edema. Can you determine the correct diagnosis?
Patients with Coronary Syndromes 3 Times More Likely to have Diabetes, More Susceptible to Adverse Outcomes
April 07, 2021
An analysis of the CLARIFY registry suggests patients with chronic coronary syndromes were 3 times more likely than the general population to have diabetes and these patients were at a greater risk of multiple adverse outcomes compared to their counterparts without diabetes.
Heart Failure Risk Among Children Born Preterm Persists Through Adulthood
April 06, 2021
An analysis of more than 4 million singleton births indicates children born at an early gestational age were at an increased risk of heart failure at multiple points throughout life when compared to their counterparts not considered preterm births.
Dapagliflozin Effective as Heart Failure Treatment for Men and Women
April 05, 2021
An analysis of the DAPA-HF trial indicates the impact of dapagliflozin were consistent across both men and women receiving the SGLT2 inhibitor.
Adverse Pregnancy Outcomes can Influence CVD Risk Later in Life
April 04, 2021
Dr. Nisha Parikh provides additional insight into the AHA's latest scientific statement, which highlights the need for greater attention and emphasis on the impact of adverse pregnancy outcomes on cardiovascular risk in women.
Study Underlines Low Rates of Screening, Treatment for Primary Aldosteronism
April 01, 2021
A study from Canada is calling for additional attention to paid to the screening, diagnosis, and treatment of primary aldosteronism in adult patients.
NYHA Class Less Sensitive than KCCQ-OS for Capturing Heart Failure Progression
March 30, 2021
An analysis of the CHAMP-HF registry indicates KCCQ-OS was more sensitive at tracking changes in disease state among heart failure patients, indicating the importance of including patient-reported outcome measures in heart failure management.
Study Calls for Increased Screening of Primary Aldosteronism
March 25, 2021
An analysis presented at ENDO 2021 suggests less than 5% of patients at high risk for primary aldosteronism undergo screening and most screenings occur after the onset of symptoms.
Transgender Youth at Increased Risk of Dyslipidemia, Other Cardiometabolic Conditions
March 20, 2021
An analysis of 4k transgender youth and 16k propensity-matched controls is providing insight into the increased risk of conditions adversely impacting the cardiometabolic health of these patients.